TwelveStone Health Partners, VirtueRN Partner to Develop Post-Acute System

Solution would aim to increase communication and cohesion for referrals, providers and patients in HME, infusion and medication services.

TwelveStone Health Partners, a provider of post-acute, chronic care medication services, and VirtueRN, a post-acute healthcare technology company, will jointly develop a software platform aiming to streamline workflows for partners in post-acute care.

The effort aims to address the fragmented market for HME, infusion and medication services that is impacting referrals, partners and patients. Objectives for the project include streamlining workflow processes and increasing communication across the post-acute care continuum.

“Technology offers the opportunity to ensure that patients get what they need faster and more efficiently,” said Shane Reeves, chief executive officer of TwelveStone Health Partners. “Our understanding of the players and shortcomings regarding post-acute medication service delivery, combined with VirtueRN’s technology prowess and knowledge of the post-acute care market, makes the combination a natural partnership opportunity.”  

A statement from TwelveStone Health Partners said the company believe VirtueRN has a “head start” having creatied its own platform, and that will facilitate getting to market more rapidly and reduce overall project investment.  

“We applaud TwelveStone for their interest in finding ways to leverage technology to address short-comings in the post-acute market,” ssaidays Gibran Ameer, chief executive officer of VirtueRN. “We look forward to leveraging our expertise and applying it to TwelveStone’s business.”

About the Author

David Kopf is the Executive Editor of HME Business and DME Pharmacy magazine. Follow him on Twitter at @postacutenews.


Add your Comment

Your Name:(optional)
Your Email:(optional)
Your Location:(optional)
Please type the letters/numbers you see above
HME Business Podcast

Subscribe to e-Source

HME Business' free email newsletter keeping you up-to-date and informed.

I agree to this site's Privacy Policy